Glucagon: Difference between revisions

Line 23: Line 23:


===[[Beta-blocker toxicity]] <ref name="KernsEMC" /> <ref name="BaileyCT" />===
===[[Beta-blocker toxicity]] <ref name="KernsEMC" /> <ref name="BaileyCT" />===
*Ped: 50mcg/kg  
*50mcg/kg  
*Rebolus if no response after 10min  
*Rebolus if no response after 10min  
*If effective, start infusion at 70mcg/kg/hr
*If effective, start infusion at 70mcg/kg/hr

Revision as of 02:15, 9 May 2016

General

  • Type:
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

Hypoglycemia

  • 1mg SC/IM/IV x 1
  • May repeat q20 min PRN

Beta-blocker toxicity[1] [2]

  • 5mg IV bolus over one minute
  • Rebolus if no response after 10min
  • If effective, start infusion at 2-5mg/hr

Pediatric Dosing

Hypoglycemia

  • 0.03 mg/kg IM/SQ/IV x 1 (max = 1 mg)
  • Alternative
    • <20kg: 0.5mg SC/IM/IV x 1
    • >20kg: 1mg SC/IM/IV x 1
  • May repeat q20 min

Beta-blocker toxicity [1] [2]

  • 50mcg/kg
  • Rebolus if no response after 10min
  • If effective, start infusion at 70mcg/kg/hr

Special Populations

  • Pregnancy Rating:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: 20 minutes
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

See Also

Sources

  1. 1.0 1.1 Kerns W. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007;25(2):309-331. (Review)
  2. 2.0 2.1 Bailey B (2003). Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. Journal of toxicology. Clinical toxicology, 41 (5), 595-602 PMID: 14514004